| Yellow fever virus (YFV) |
Randomized controlled trial (RCT) |
Reduction in yellow fever vaccine viraemia, which was positively associated with IL-1ß production |
Arts et al. [36]
|
- |
| Human Papilloma virus (HPV) |
Randomized controlled trial (RCT) |
Improved clearance of the HPV caused viral warts |
Salem et al. [24]
|
80 participants (randomized into 40 test and 40 control subjects) |
|
Randomized controlled trial (RCT) |
|
Podder et al. [25]
|
60 participants (randomized into 33 participants in BCG group and 27 in tuberculin purified protein group |
|
Case series |
|
Daulatabad et al. [26]
|
7 cases (wart regression seen in 85.7% of patients and complete resolution in 28.6%) |
| Respiratory syncytial virus (RCV) |
Case-control study |
Fewer cases of RSV infection in BCG vaccinated children in Guinea-Bissau |
Stensballe et al. [21]
|
386 cases (participants with lower respiratory tract infections were more likely to be BCG unvaccinated i.e. higher odds ratio) |
| Influenza virus type A (H1N1) |
Randomized controlled trial (RCT) |
Improved immunogenicity of the H1N1 vaccine, manifesting as increased H1N1 antibody production |
Leentjens et al. [32]
|
40 participants (randomized into 20 test and 20 control subjects) |
| Herpes Simplex Virus (HSV) |
Case series |
Reduced episodes of HSV infection recurrence |
Anderson et al. [37]
|
15 cases |
|
Case series |
|
Hippman et al. [38]
|
109 cases (all participants remained herpes-free for 4–6 months, 21% after 3 years and 10% after 6 years) |
